Triazole-Based Alzheimer’s Therapeutics

Technical Description This technology describes the multitarget triazole-bridged cycloaryl analogues with dual cholinesterase inhibition, neuroprotective effects, and anti-amyloid β aggregation for Alzheimer’s disease treatment. Problems Addressed Limited Therapeutic Options Ineffective Multi-Target Inhibition Unsuccessful Drug Trials Inadequate Neuroprotection High Disease Burden…









